Onco, the international peer-reviewed open access journal on oncotargets and cancer therapies published by MDPI, has been accepted for coverage in the Scopus indexing database as of November 2025. The update marks a key development for the journal, which has continued to expand submissions and readership since launch. Authors, reviewers, and editors were acknowledged in the announcement for contributing to the journal’s progress.
Onco publishes research papers, reviews, editorials, and communications and encourages detailed reporting of experimental and theoretical findings to support reproducibility. The journal is positioned as a forum for integrating novel preclinical, translational, and clinical cancer research, maintaining a primary focus on oncotargets and oncology-related therapies.
The Editorial Board includes experts from leading institutions, oncology centers, and universities in cancer research who support the journal’s aim of promoting developments across the oncology field. The Scopus update is expected to enhance visibility for content aligned with these areas.
Researchers working on topics within the journal’s scope are invited to submit manuscripts through the Onco website.
Click here to read the original press release.
